United Services Automobile Association’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,165
Closed -$367K 1406
2019
Q2
$367K Hold
8,165
﹤0.01% 1775
2019
Q1
$307K Buy
8,165
+1,299
+19% +$43.6K ﹤0.01% 1881
2018
Q4
$236K Hold
6,866
﹤0.01% 1939
2018
Q3
$323K Buy
+6,866
New +$284K ﹤0.01% 1900
2017
Q1
Sell
-30,110
Closed -$329K 1362
2016
Q4
$329K Buy
30,110
+750
+3% +$7.87K ﹤0.01% 1265
2016
Q3
$411K Buy
29,360
+2,600
+10% +$21.1K ﹤0.01% 1248
2016
Q2
$188K Sell
26,760
-750
-3% -$5.5K ﹤0.01% 1262
2016
Q1
$177K Sell
27,510
-9,130
-25% -$158K ﹤0.01% 1272
2015
Q4
$1.19M Buy
36,640
+5,030
+16% +$148K ﹤0.01% 1048
2015
Q3
$844K Buy
31,610
+1,920
+6% +$82.1K ﹤0.01% 1097
2015
Q2
$1.43M Buy
29,690
+1,940
+7% +$113K 0.01% 1055
2015
Q1
$1.69M Sell
27,750
-62,017
-69% -$3.78M 0.01% 1004
2014
Q4
$4.65M Sell
89,767
-2,170
-2% -$95.5K 0.02% 730
2014
Q3
$4.05M Hold
91,937
0.01% 742
2014
Q2
$2.4M Hold
91,937
0.01% 896
2014
Q1
$2.4M Buy
+91,937
New +$2.47M 0.01% 892

Other funds holding PTCT

United Services Automobile Association's PTCT Position: Q3 2019 in Review

United Services Automobile Association sold out of PTC Therapeutics (PTCT) in Q3 2019, closing a stake of 8,165 shares — an estimated $367K sold.

United Services Automobile Association first reported a position in PTCT in Q1 2014 and held it in 16 quarters. The position peaked at $4.65M in Q4 2014. 184 funds tracked by Wall St. Rank hold PTCT as of Q3 2019.

  • United Services Automobile Association reported no remaining PTC Therapeutics position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 8,165 PTC Therapeutics shares in Q3 2019, an estimated $367K.
  • United Services Automobile Association first reported a position in PTC Therapeutics in Q1 2014 and held it in 16 quarters.
  • United Services Automobile Association's PTC Therapeutics position peaked at $4.65M in Q4 2014.
  • 184 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.